Deglycosylated bleomycin triggers apoptosis in laryngeal carcinoma cells in a caspase and reactive oxygen species independent manner

Journal of Oral Pathology and Medicine

Volumn 37, Issue 6, 2008, Pages 352-357

  Brahim, Souhir ^a   Bettaieb, Ali ^b,c   Kenani, Abderraouf ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c PSL RESEARCH UNIVERSITY   (France)

Author keywords

Apoptosis; Bleomycin A2; Deglycobleomycin A2; HEp 2 laryngeal carcinoma cells

Indexed keywords

BLEOMYCIN A2; BLEOMYCIN DERIVATIVE; CASPASE; DEGLYCOBLEOMYCIN A2; REACTIVE OXYGEN METABOLITE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CLONOGENIC ASSAY; COMPARATIVE TOXICOLOGY; CYTOTOXICITY TEST; DEGLYCOSYLATION; DOSE TIME EFFECT RELATION; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG SAFETY; ENZYME ACTIVATION; HEP 2 CELL; HUMAN; HUMAN CELL; LARYNX CARCINOMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BLEOMYCIN; BLOTTING, WESTERN; CASPASES; CELL LINE, TUMOR; HUMANS; LARYNGEAL NEOPLASMS; REACTIVE OXYGEN SPECIES;

EID: 44949107203     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2007.00621.x     Document Type: Article

References (38)

1. Umezawa H, Maeda K, Takenchi T, Okama Y. New antibiotics, bleomycin A and B. J Antibiot 1966 Ser. A19 : 200 9.
2. Burger RM. Cleavage of nucleic acids by bleomycin. Chem Rev 1989 98 : 1153 69.
3. Sam JW, Peisach P. EPR spectroscopic investigation of lability of oxygen in activated bleomycin: implications for the mechanism of bleomycin-mediated DNA degradation. Biochemistry 1993 32 : 1488 91.
4. Lehmann TE, Ming LI-J, Rosen ME, Lawrence QJ. NMR studies of the paramagnetic complex Fe(II)-bleomycin. Biochemistry 1997 36 : 28107 67.
5. Kenani A, Lohez M, Houssin R, et al. Chelating, DNA-binding and DNA-cleaving properties of a synthetic model for bleomycin. Anticancer Drug Des 1987 2 : 47 59.
6. Chien M, Grollman AP, Horwitz SB. Bleomycin-DNA interactions: fluorescence and proton magnetic resonance studies. Biochemistry 1977 16 : 3641.
7. Tounekti O, Kenani A, Foray N, Orlowski S, MIR LM. The ratio of single to double-strand DNA breaks and their absolute values determine cell death pathway. Br J Cancer 2001 84 : 1272 9.
8. Ichikawa T, Nakano I, Hirokawa I. Bleomycin treatment of the tumors of penis and scrotum. J Urol 1969 102 : 699 707.
9. Terasima T, Umezawa H. Lethal effect of Bleomycin on cultured mammalian cells. J Antibiot 1970 23 : 300 4.
10. Hagimoto N, Kuwano K, Miyazaki H, et al. Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of Fas antigen. Am J Respir Cell Mol Biol 1997 17 : 272 8.
11. Martin SJ, Green DR. Apoptosis as a goal of cancer therapy. Curr Opin Oncol 1994 6 : 616 21.
12. Hu W, Kavanagh JJ. Anticancer therapy targeting the apoptotic pathway. Lancet Oncol 2003 4 : 721 9.
13. Alnemri ES, Livingston DJ, Nicholson DW, et al. Human ICE/CED-3 protease nomenclature. Cell 1996 87 : 171.
14. Boatright KM, Salvesen GS. Mechanisms of caspase activation. Curr Opin Cell Biol 2003 15 : 725 31.
15. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998 281 : 1312 6.
16. Green DR. Apoptotic pathways: paper wraps stone blunts scissors. Cell 2000 102 : 1 4.
17. Thorburn A. Death receptor-induced cell killing: a review. Cell Signal 2004 16 : 139 44.
18. Filomenko R, Prevotat L, Rebe C, et al. Caspase-10 involvement in cytotoxic drug-induced apoptosis of tumor cells. Oncogene 2006 25 : 7635 45.
19. Decaudin D, Marzo I, Brenner C, Kroemer G. Mitochondria in chemotherapy-induced apoptosis: a prospective novel target of cancer therapy: a review. Int J Oncol 1998 12 : 141 52.
20. Kluck RM, Bossy-wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997 275 : 1132 6.
21. Caporossi D, Ciafre SA, Pittaluga M, Savini I, Farace MG. Cellular responses to H2O2 and bleomycin-induced oxidative stress in L6C5 rat myoblasts. Free Radic Biol Med 2003 35 : 1355 64.
22. Ramotar D, Wang H. Protective mechanisms against the antitumor agent bleomycin: lessons from Saccharomyces cerevisiae. Curr Genet 2003 43 : 213 24.
23. Sakakibara S. In : Weinstein B, ed. Chemistry and biochemistry of amino acids, peptides and proteins, Volume 1. New York : Marcel Dekker, 1971 51 85.
24. Kenani A, Lamblin G, Henichart JP. A convenient method for the cleavage of the D-mannosyl-L-gulose disaccharide from bleomycin-A2. Carbohydr Res 1988 177 : 81 9.
25. Sausville EA, Peisach J, Horwitz SB. Effect of chelating agents and metal ions on the degradation of DNA by bleomycin. Biochemistry 1978 17 : 2740 6.
26. Galvan L, Huang CH, Prestayko AW, et al. Inhibition of bleomycin-induced DNA breakage by superoxide dismutase. Cancer Res 1981 41 (12 Pt 1 5103 6.
27. Gillissen A, Nowak D. Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy. Respir Med 1998 92 : 609 23.
28. Weiss RB, Muggia FM. Cytotoxic drug-induced pulmonary disease: update 1980: a review. Am J Med 1980 68 : 259 66.
29. Hagimoto N, Kuwano K, Nomoto Y, Kunitake R, Hara N. Apoptosis and expression of Fas/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice. Am J Respir Cell Mol Biol 1997 16 : 91 101.
30. Duggan DB, Petroni GR, Johnson JL, et al. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial. J Clin Oncol 2003 21 : 607 14.
31. Wang R, Ibarra-sunga O, Verlinski L, Pick R, Uhal BD. Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor. Am J Physiol Lung Cell Mol Physiol 2000 279 : L143 51.
32. Kuwano K, Kunitake R, Maeyama T, et al. Attenuation of bleomycin-induced pneumopathy in mice by a caspase inhibitor. Am J Physiol Lung Cell Mol Physiol 2001 280 : L316 25.
33. Bailly C, Kenani A, Waring MJ. Altered cleavage of DNA sequences by bleomycin and its deglycosylated derivative in the presence of actinomycin. Nucleic Acids Res 1997 25 : 1516 22.
34. Kenani A, Bailly C, Houssin R, Henichard JP. Comparative subcellular distribution of the copper complexes of bleomycin-A2 and deglycobleomycin-A2. Anticancer Drugs 1994 5 : 199 201.
35. Lee VY, Schroedl C, Brunelle JK, et al. Bleomycin induces alveolar epithelial cell death through JNK-dependent activation of the mitochondrial death pathway. Am J Physiol Lung Cell Mol Physiol 2005 289 : L521 8.
36. Saeki K, Kobayashi N, Inazawa Y, et al. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis. Biochem J 2002 368 (Pt 3) : 705 20.
37. Lei K, Nimnual A, Zong WX, et al. The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-Jun NH(2)-terminal kinase. Mol Cell Biol 2002 22 : 4929 42.
38. Tournier C, Hess P, Yang DD, et al. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 2000 288 : 870 4.